HomeANEB • NASDAQ
add
Anebulo Pharmaceuticals Inc
Previous close
$2.75
Day range
$2.71 - $2.77
Year range
$0.80 - $3.42
Market cap
112.57M USD
Avg Volume
79.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.33M | 73.90% |
Net income | -2.14M | -58.88% |
Net profit margin | — | — |
Earnings per share | -0.05 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.63M | 275.80% |
Total assets | 12.15M | 198.19% |
Total liabilities | 487.69K | 87.15% |
Total equity | 11.66M | — |
Shares outstanding | 41.08M | — |
Price to book | 9.82 | — |
Return on assets | -44.56% | — |
Return on capital | -46.39% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.14M | -58.88% |
Cash from operations | -1.65M | 19.53% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -1.65M | 19.53% |
Free cash flow | -974.93K | 38.22% |
About
Founded
2020
Headquarters
Website
Employees
3
